These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 25332110)

  • 1. Parkin mutations reduce the complexity of neuronal processes in iPSC-derived human neurons.
    Ren Y; Jiang H; Hu Z; Fan K; Wang J; Janoschka S; Wang X; Ge S; Feng J
    Stem Cells; 2015 Jan; 33(1):68-78. PubMed ID: 25332110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkin mutation decreases neurite complexity and maturation in neurons derived from human fibroblasts.
    Pu J; Gao T; Zheng R; Fang Y; Ruan Y; Jin C; Shen T; Tian J; Zhang B
    Brain Res Bull; 2020 Jun; 159():9-15. PubMed ID: 32156628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkin Maintains Robust Pacemaking in Human Induced Pluripotent Stem Cell-Derived A9 Dopaminergic Neurons.
    Pu J; Lin L; Jiang H; Hu Z; Li H; Yan Z; Zhang B; Feng J
    Mov Disord; 2023 Jul; 38(7):1273-1281. PubMed ID: 37166002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells.
    Jiang H; Ren Y; Yuen EY; Zhong P; Ghaedi M; Hu Z; Azabdaftari G; Nakaso K; Yan Z; Feng J
    Nat Commun; 2012 Feb; 3():668. PubMed ID: 22314364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkin protects dopaminergic neurons against microtubule-depolymerizing toxins by attenuating microtubule-associated protein kinase activation.
    Ren Y; Jiang H; Yang F; Nakaso K; Feng J
    J Biol Chem; 2009 Feb; 284(6):4009-17. PubMed ID: 19074146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine Induces Oscillatory Activities in Human Midbrain Neurons with Parkin Mutations.
    Zhong P; Hu Z; Jiang H; Yan Z; Feng J
    Cell Rep; 2017 May; 19(5):1033-1044. PubMed ID: 28467897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of three induced pluripotent stem cell lines from a Parkinson's disease patient with mutant PARKIN (p. C253Y).
    Tariq M; Liu H; Ibañez DP; Li Y; Chen S; Jiang M; Fan W; Zhao P; Luo Z; Wang D; Kanwal S
    Stem Cell Res; 2020 May; 45():101822. PubMed ID: 32387897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microtubule: a common target for parkin and Parkinson's disease toxins.
    Feng J
    Neuroscientist; 2006 Dec; 12(6):469-76. PubMed ID: 17079513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotenone selectively kills serotonergic neurons through a microtubule-dependent mechanism.
    Ren Y; Feng J
    J Neurochem; 2007 Oct; 103(1):303-11. PubMed ID: 17587308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism.
    Okarmus J; Havelund JF; Ryding M; Schmidt SI; Bogetofte H; Heon-Roberts R; Wade-Martins R; Cowley SA; Ryan BJ; Færgeman NJ; Hyttel P; Meyer M
    Stem Cell Reports; 2021 Jun; 16(6):1510-1526. PubMed ID: 34048689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.
    Jiang H; Ren Y; Zhao J; Feng J
    Hum Mol Genet; 2004 Aug; 13(16):1745-54. PubMed ID: 15198987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation.
    Ren Y; Zhao J; Feng J
    J Neurosci; 2003 Apr; 23(8):3316-24. PubMed ID: 12716939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLP-2 interacts with Parkin in mitochondria and prevents mitochondrial dysfunction in Parkin-deficient human iPSC-derived neurons and Drosophila.
    Zanon A; Kalvakuri S; Rakovic A; Foco L; Guida M; Schwienbacher C; Serafin A; Rudolph F; Trilck M; Grünewald A; Stanslowsky N; Wegner F; Giorgio V; Lavdas AA; Bodmer R; Pramstaller PP; Klein C; Hicks AA; Pichler I; Seibler P
    Hum Mol Genet; 2017 Jul; 26(13):2412-2425. PubMed ID: 28379402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkin absence accelerates microtubule aging in dopaminergic neurons.
    Cartelli D; Amadeo A; Calogero AM; Casagrande FVM; De Gregorio C; Gioria M; Kuzumaki N; Costa I; Sassone J; Ciammola A; Hattori N; Okano H; Goldwurm S; Roybon L; Pezzoli G; Cappelletti G
    Neurobiol Aging; 2018 Jan; 61():66-74. PubMed ID: 29040870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling Parkinson's disease using induced pluripotent stem cells.
    Byers B; Lee HL; Reijo Pera R
    Curr Neurol Neurosci Rep; 2012 Jun; 12(3):237-42. PubMed ID: 22538490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.
    Giguère N; Pacelli C; Saumure C; Bourque MJ; Matheoud D; Levesque D; Slack RS; Park DS; Trudeau LÉ
    J Biol Chem; 2018 Jun; 293(25):9580-9593. PubMed ID: 29700116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iPS models of Parkin and PINK1.
    Rakovic A; Seibler P; Klein C
    Biochem Soc Trans; 2015 Apr; 43(2):302-7. PubMed ID: 25849934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells.
    Li H; Jiang H; Zhang B; Feng J
    J Parkinsons Dis; 2018; 8(4):479-493. PubMed ID: 30149462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Parkin in the Neuronal Progenitor Cells from a Patient with Parkinson's Disease Shifts the Transcriptome Towards the Normal State.
    Lebedeva O; Poberezhniy D; Novosadova E; Gerasimova T; Novosadova L; Arsenyeva E; Stepanenko E; Shimchenko D; Volovikov E; Anufrieva K; Illarioshkin S; Lagarkova M; Grivennikov I; Tarantul V; Nenasheva V
    Mol Neurobiol; 2023 Jun; 60(6):3522-3533. PubMed ID: 36884134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.